StemCells: Press Releases

News > Press Releases

Date	Title (click to view the full text)
3/11/2010	StemCells, Inc. Reports Fourth Quarter and Fiscal 2009 Financial Results
2/16/2010	StemCells, Inc. Launches Cell Culture Medium Enabling the Derivation and Maintenance of True Mouse iPS Cells
2/10/2010	StemCells, Inc. Announces First Human Neural Stem Cell Transplant in Landmark Myelination Disorder Trial
2/3/2010	LifeTech Capital Initiates Research Coverage of StemCells, Inc. with Strong Speculative Buy Recommendation
1/25/2010	StemCells, Inc. Launches First Cell Culture Medium to Enable Derivation and Maintenance of True Rat Embryonic Stem Cells
12/15/2009	StemCells, Inc. Strengthens Patent Position in Embryonic and Induced Pluripotent Stem Cell Technology Platforms
12/3/2009	StemCells, Inc. Welcomes Approval of First Embryonic Stem Cell Lines Under New NIH Guidelines
11/23/2009	StemCells, Inc. CEO Martin McGlynn Featured on BioBusiness.TV's "Stem Cell Review" Series
11/23/2009	StemCells, Inc. Initiates Landmark Trial Targeting "Communication Highway" of the Brain
11/18/2009	StemCells, Inc. Provides Update on NCL Program Meeting with FDA
11/5/2009	StemCells, Inc. Reports Third Quarter Financial Results
11/3/2009	StemCells, Inc. Closes $12.5 Million Equity Financing
10/28/2009	StemCells, Inc. Announces $12.5 Million Equity Financing
10/19/2009	StemCells, Inc.'s Neural Stem Cells Show Promise for Treating Age-Related Macular Degeneration